Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:CTIC

CTI BioPharma (CTIC) Stock Price, News & Analysis

CTI BioPharma logo

About CTI BioPharma Stock (NASDAQ:CTIC)

Advanced Chart

Key Stats

Today's Range
$9.09
$9.09
50-Day Range
$8.91
$9.10
52-Week Range
$4.01
$9.10
Volume
N/A
Average Volume
4.50 million shs
Market Capitalization
$1.20 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive CTIC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CTI BioPharma and its competitors with MarketBeat's FREE daily newsletter.

CTIC Stock News Headlines

Which Gold Miner Trades at 30% of NAV? The One Buffett Wants
Some of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. With gold at record highs and Bridgewater now buying in, one analyst believes Buffett’s next move could hit by August 15th. He’s identified the gold miner that fits Buffett’s profile — plus four smaller plays with even more upside.
See More Headlines

CTIC Stock Analysis - Frequently Asked Questions

CTI BioPharma Corp. (NASDAQ:CTIC) released its quarterly earnings results on Monday, March, 6th. The biopharmaceutical company reported ($0.14) EPS for the quarter, missing analysts' consensus estimates of ($0.10) by $0.04. The biopharmaceutical company earned $21.08 million during the quarter, compared to the consensus estimate of $24.88 million.
Read the conference call transcript
.

CTI BioPharma's stock reverse split before market open on Tuesday, January 3rd 2017.The 1-10 reverse split was announced on Friday, December 9th 2016. The number of shares owned by shareholders was adjusted after the closing bell on Friday, December 30th 2016. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that CTI BioPharma investors own include Edap Tms (EDAP), Energous (WATT), Adverum Biotechnologies (ADVM), Weatherford International (WFT), XOMA Royalty (XOMA), Advanced Micro Devices (AMD) and Sorrento Therapeutics (SRNE).

Company Calendar

Last Earnings
3/06/2023
Today
7/14/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:CTIC
Previous Symbol
NASDAQ:CTICD
CIK
891293
Employees
127
Year Founded
1992

Profitability

EPS (Trailing Twelve Months)
($0.58)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$92.99 million
Net Margins
-91.38%
Pretax Margin
-91.38%
Return on Equity
N/A
Return on Assets
-55.82%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.27
Quick Ratio
1.26

Sales & Book Value

Annual Sales
$53 million
Price / Sales
22.62
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.14) per share
Price / Book
-64.93

Miscellaneous

Outstanding Shares
131,880,000
Free Float
121,844,000
Market Cap
$1.20 billion
Optionable
Optionable
Beta
0.83

Social Links

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (NASDAQ:CTIC) was last updated on 7/14/2025 by MarketBeat.com Staff
From Our Partners